{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:19:00Z","timestamp":1774945140837,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,31]]},"group-title":"In Review","reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,19]]},"abstract":"<title>Abstract<\/title>\n                <p>Mammarenaviruses are endemic in rodent populations worldwide, and their zoonotic transmission can lead to a severe, life-threatening hemorrhagic fever (HF) syndrome. In the Americas, five New World mammarenaviruses (NWMs) are known to cause HF. In the absence of FDA-licensed vaccines or antiviral therapies, these viruses pose a significant public health risk and a threat to national security. Research into NWM pathogenesis and the development of effective countermeasures is severely limited by the lack of small-animal models that faithfully reproduce human disease. The pathogenic NWMs use human transferrin receptor 1 (hTfR1) as the receptor for cellular entry. Here, we describe the development of an hTfR1 knock-in (KI) golden Syrian hamster line and its susceptibility to Jun\u00edn virus (JUNV) infection. This transgenic hamster infection model supports TfR1-mediated entry as an essential step in JUNV pathogenesis and provides a novel small-animal model to advance the development of promising host receptor-directed therapies and direct-acting antivirals to improve outcomes in patients with severe disease caused by pathogenic NWMs.<\/p>","DOI":"10.21203\/rs.3.rs-9172948\/v1","type":"posted-content","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:54:56Z","timestamp":1774940096000},"source":"Crossref","is-referenced-by-count":0,"title":["A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus Infection"],"prefix":"10.21203","author":[{"given":"Samantha R.","family":"Wasson","sequence":"first","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Liu","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghao","family":"Li","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonna B.","family":"Westover","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Landinez-Aponte","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud Van","family":"Wettere","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatraman","family":"Siddharthan","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Davies","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy R.","family":"Daniels-Wells","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel L.","family":"Penichet","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongde","family":"Wang","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian B.","family":"Gowen","sequence":"additional","affiliation":[{"name":"Utah State University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Lendino, A., Castellanos, A. A., Pigott, D. M. & Han, B. A. A review of emerging health threats from zoonotic New World mammarenaviruses. BMC Microbiol 24, 115 (2024). https:\/\/doi.org\/10.1186\/s12866-024-03257-w","DOI":"10.1186\/s12866-024-03257-w"},{"key":"ref2","unstructured":"2. NIAID. NIAID Biodefense Pathogens, <https:\/\/www.niaid.nih.gov\/research\/niaid-biodefense-pathogens> (2024)."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Geisbert, T. W. & Jahrling, P. B. Exotic emerging viral diseases: progress and challenges. Nat Med 10, S110\u2013121 (2004).","DOI":"10.1038\/nm1142"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Peters, C. J. Human infection with arenaviruses in the Americas. Curr Top Microbiol Immunol 262, 65\u201374 (2002). https:\/\/doi.org\/10.1007\/978-3-642-56029-3_3","DOI":"10.1007\/978-3-642-56029-3_3"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Ortiz-Prado, E. et al. Hemorrhagic fevers caused by South American Mammarenaviruses: A comprehensive review of epidemiological and environmental factors related to potential emergence. Travel Med Infect Dis 64, 102827 (2025). https:\/\/doi.org\/10.1016\/j.tmaid.2025.102827","DOI":"10.1016\/j.tmaid.2025.102827"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Delgado, S. et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog 4, e1000047 (2008). https:\/\/doi.org\/10.1371\/journal.ppat.1000047","DOI":"10.1371\/journal.ppat.1000047"},{"key":"ref7","unstructured":"7. Centers for Disease, C. & Prevention. Fatal illnesses associated with a new world arenavirus\u2013California, 1999\u20132000. MMWR Morb Mortal Wkly Rep 49, 709\u2013711 (2000)."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Enria, D. A., Briggiler, A. M. & Sanchez, Z. Treatment of Argentine hemorrhagic fever. Antiviral Res 78, 132\u2013139 (2008). https:\/\/doi.org\/10.1016\/j.antiviral.2007.10.010","DOI":"10.1016\/j.antiviral.2007.10.010"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Paessler, S. & Walker, D. H. Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 8, 411\u2013440 (2013). https:\/\/doi.org\/10.1146\/annurev-pathol-020712-164041","DOI":"10.1146\/annurev-pathol-020712-164041"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Frank, M. G. et al. South American Hemorrhagic Fevers: A summary for clinicians. Int J Infect Dis 105, 505\u2013515 (2021). https:\/\/doi.org\/10.1016\/j.ijid.2021.02.046","DOI":"10.1016\/j.ijid.2021.02.046"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Golden, J. W., Hammerbeck, C. D., Mucker, E. M. & Brocato, R. L. Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses. BioMed research international 2015, 793257 (2015). https:\/\/doi.org\/10.1155\/2015\/793257","DOI":"10.1155\/2015\/793257"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Smith, D. R., Holbrook, M. R. & Gowen, B. B. Animal models of viral hemorrhagic fever. Antiviral Res 112, 59\u201379 (2014). https:\/\/doi.org\/10.1016\/j.antiviral.2014.10.001","DOI":"10.1016\/j.antiviral.2014.10.001"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Bradfute, S. B., Stuthman, K. S., Shurtleff, A. C. & Bavari, S. A STAT-1 knockout mouse model for Machupo virus pathogenesis. Virol J 8, 300 (2011). https:\/\/doi.org\/10.1186\/1743-422X-8-300","DOI":"10.1186\/1743-422X-8-300"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Patterson, M. et al. Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (alphabeta\/gamma) receptor double knockout mice. J Virol 88, 1914\u20131923 (2014). https:\/\/doi.org\/10.1128\/JVI.02925-13","DOI":"10.1128\/JVI.02925-13"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Kolokoltsova, O. A. et al. Mice lacking alpha\/beta and gamma interferon receptors are susceptible to junin virus infection. J Virol 84, 13063\u201313067 (2010). https:\/\/doi.org\/10.1128\/JVI.01389-10","DOI":"10.1128\/JVI.01389-10"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Yun, N. E. et al. Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. Am J Trop Med Hyg 79, 275\u2013282 (2008). https:\/\/doi.org\/79\/2\/275 [pii]","DOI":"10.4269\/ajtmh.2008.79.275"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Welch, S. R. et al. Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal disease. Sci Transl Med 16, eado7034 (2024). https:\/\/doi.org\/10.1126\/scitranslmed.ado7034","DOI":"10.1126\/scitranslmed.ado7034"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Gowen, B. B. et al. Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junin Virus Infection in Guinea Pigs. J Virol 95, e0039721 (2021). https:\/\/doi.org\/10.1128\/JVI.00397-21","DOI":"10.1128\/JVI.00397-21"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Westover, J. B. et al. Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir. Antiviral Res 208, 105444 (2022). https:\/\/doi.org\/10.1016\/j.antiviral.2022.105444","DOI":"10.1016\/j.antiviral.2022.105444"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Kenyon, R. H., Green, D. E., Eddy, G. A. & Peters, C. J. Treatment of junin virus-infected guinea pigs with immune serum: development of late neurological disease. J Med Virol 20, 207\u2013218 (1986).","DOI":"10.1002\/jmv.1890200303"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Kenyon, R. H., Green, D. E., Maiztegui, J. I. & Peters, C. J. Viral strain dependent differences in experimental Argentine hemorrhagic fever (Junin virus) infection of guinea pigs. Intervirology 29, 133\u2013143 (1988).","DOI":"10.1159\/000150039"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Zeitlin, L. et al. Monoclonal antibody therapy for Junin virus infection. Proc Natl Acad Sci U S A 113, 4458\u20134463 (2016). https:\/\/doi.org\/10.1073\/pnas.1600996113","DOI":"10.1073\/pnas.1600996113"},{"key":"ref23","unstructured":"23. Webb, P. A., Justines, G. & Johnson, K. M. Infection of wild and laboratory animals with Machupo and Latino viruses. Bull World Health Organ 52, 493\u2013499 (1975)."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Tesh, R. B., Jahrling, P. B., Salas, R. & Shope, R. E. Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am J Trop Med Hyg 50, 452\u2013459 (1994). https:\/\/doi.org\/10.4269\/ajtmh.1994.50.452","DOI":"10.4269\/ajtmh.1994.50.452"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Hall, W. C., Geisbert, T. W., Huggins, J. W. & Jahrling, P. B. Experimental infection of guinea pigs with Venezuelan hemorrhagic fever virus (Guanarito): a model of human disease. Am J Trop Med Hyg 55, 81\u201388 (1996).","DOI":"10.4269\/ajtmh.1996.55.81"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Bell, T. M. et al. Pathogenesis of Bolivian Hemorrhagic Fever in Guinea Pigs. Vet Pathol 53, 190\u2013199 (2016). https:\/\/doi.org\/10.1177\/0300985815588609","DOI":"10.1177\/0300985815588609"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Golden, J. W., Maes, P., Kwilas, S. A., Ballantyne, J. & Hooper, J. W. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever. J Virol 90, 3515\u20133529 (2016). https:\/\/doi.org\/10.1128\/JVI.02969-15","DOI":"10.1128\/JVI.02969-15"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Grant, A. et al. Junin virus pathogenesis and virus replication. Viruses 4, 2317\u20132339 (2012). https:\/\/doi.org\/10.3390\/v4102317","DOI":"10.3390\/v4102317"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Radoshitzky, S. R. et al. Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses. Proc Natl Acad Sci U S A 105, 2664\u20132669 (2008). https:\/\/doi.org\/10.1073\/pnas.0709254105","DOI":"10.1073\/pnas.0709254105"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Abraham, J. et al. Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. PLoS Pathog 5, e1000358 (2009). https:\/\/doi.org\/10.1371\/journal.ppat.1000358","DOI":"10.1371\/journal.ppat.1000358"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Radoshitzky, S. R. et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446, 92\u201396 (2007). https:\/\/doi.org\/10.1038\/nature05539","DOI":"10.1038\/nature05539"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Zong, M., Fofana, I. & Choe, H. Human and host species transferrin receptor 1 use by North American arenaviruses. J Virol 88, 9418\u20139428 (2014). https:\/\/doi.org\/10.1128\/JVI.01112-14","DOI":"10.1128\/JVI.01112-14"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Enserink, M. Emerging diseases. New arenavirus blamed for recent deaths in California. Science 289, 842\u2013843 (2000). https:\/\/doi.org\/10.1126\/science.289.5481.842","DOI":"10.1126\/science.289.5481.842"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Sarute, N. & Ross, S. R. New World Arenavirus Biology. Annu Rev Virol 4, 141\u2013158 (2017). https:\/\/doi.org\/10.1146\/annurev-virology-101416-042001","DOI":"10.1146\/annurev-virology-101416-042001"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Hickerson, B. T., Westover, J. B., Wang, Z., Lee, Y. M. & Gowen, B. B. Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junin Virus and Other Pathogenic New World Arenaviruses. J Virol 94, e01278\u201301219 (2020). https:\/\/doi.org\/10.1128\/JVI.01278-19","DOI":"10.1128\/JVI.01278-19"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Helguera, G. et al. An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic Fever arenaviruses. J Virol 86, 4024\u20134028 (2012). https:\/\/doi.org\/10.1128\/JVI.06397-11","DOI":"10.1128\/JVI.06397-11"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. Choe, H., Jemielity, S., Abraham, J., Radoshitzky, S. R. & Farzan, M. Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses. Curr Opin Microbiol 14, 476\u2013482 (2011). https:\/\/doi.org\/10.1016\/j.mib.2011.07.014","DOI":"10.1016\/j.mib.2011.07.014"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"38. Hickerson, B. T. et al. Type I interferon underlies severe disease associated with Junin virus infection in mice. Elife 9, e55352 (2020). https:\/\/doi.org\/10.7554\/eLife.55352","DOI":"10.7554\/eLife.55352"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. Schnittler, H. J. & Feldmann, H. Viral hemorrhagic fever\u2013a vascular disease? Thromb Haemost 89, 967\u2013972 (2003).","DOI":"10.1055\/s-0037-1613397"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"40. Aleksandrowicz, P. et al. Viral haemorrhagic fever and vascular alterations. Hamostaseologie 28, 77\u201384 (2008). https:\/\/doi.org\/08010077 [pii]","DOI":"10.1055\/s-0037-1616926"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Sbrana, E. et al. Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with Pirital virus (Arenaviridae): a rodent model of Lassa fever. Am J Trop Med Hyg 74, 1096\u20131102 (2006).","DOI":"10.4269\/ajtmh.2006.74.1096"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"42. Vela, E. M. et al. Genistein, a general kinase inhibitor, as a potential antiviral for arenaviral hemorrhagic fever as described in the Pirital virus-Syrian golden hamster model. Antiviral Res 87, 318\u2013328 (2010). https:\/\/doi.org\/S0166-3542(10)00640-6 [pii]","DOI":"10.1016\/j.antiviral.2010.06.007"},{"key":"ref43","unstructured":"10. 1016\/j.antiviral.2010.06.007 43 Gowen, B. B. et al. Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virol J 7, 240 (2010). https:\/\/doi.org\/10.1186\/1743-422X-7-240 44 Kunz, S. The role of the vascular endothelium in arenavirus haemorrhagic fevers. Thromb Haemost 102, 1024\u20131029 (2009). https:\/\/doi.org\/09-06-0357 [pii]"},{"key":"ref44","unstructured":"10. 1160\/TH09-06-0357 45 Marzi, A. et al. A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever. Sci Rep 6, 39214 (2016). https:\/\/doi.org\/10.1038\/srep39214 46 Murphy, F. A., Buchmeier, M. J. & Rawls, W. E. The reticuloendothelium as the target in a virus infection. Pichinde virus pathogenesis in two strains of hamsters. Lab Invest 37, 502\u2013515 (1977). 47 Sanger, F., Nicklen, S. & Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74, 5463\u20135467 (1977). https:\/\/doi.org\/10.1073\/pnas.74.12.5463 48 Green, D. E., Mahlandt, B. G. & McKee, K. T., Jr. Experimental Argentine hemorrhagic fever in rhesus macaques: virus-specific variations in pathology. J Med Virol 22, 113\u2013133 (1987). 49 Avila, M. M., Samoilovich, S. R., Laguens, R. P., Merani, M. S. & Weissenbacher, M. C. Protection of Junin virus-infected marmosets by passive administration of immune serum: association with late neurologic signs. J Med Virol 21, 67\u201374 (1987). 50 Scolaro, L. A. & Damonte, E. B. Calomys musculinus, the natural reservoir of Argentine haemorrhagic fever, is a semipermissive host for a mouse-attenuated mutant of Junin virus. Res Virol 145, 331\u2013336 (1994). https:\/\/doi.org\/10.1016\/s0923-2516(07)80038-0 51 Trichas, G., Begbie, J. & Srinivas, S. Use of the viral 2A peptide for bicistronic expression in transgenic mice. BMC Biol 6, 40 (2008). https:\/\/doi.org\/10.1186\/1741-7007-6-40 52 Wang, X. & Marchisio, M. A. Synthetic polycistronic sequences in eukaryotes. Synth Syst Biotechnol 6, 254\u2013261 (2021). https:\/\/doi.org\/10.1016\/j.synbio.2021.09.003 53 Feng, Y. Q., Lorincz, M. C., Fiering, S., Greally, J. M. & Bouhassira, E. E. Position effects are influenced by the orientation of a transgene with respect to flanking chromatin. Mol Cell Biol 21, 298\u2013309 (2001). https:\/\/doi.org\/10.1128\/MCB.21.1.298-309.2001 54 Hickerson, B. T. et al. Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections. Nat Commun 13, 558 (2022). https:\/\/doi.org\/10.1038\/s41467-021-27949-3 55 Gowen, B. B. et al. Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir. J Virol 91 (2017). https:\/\/doi.org\/10.1128\/JVI.01942-16 56 Westover, J. B. et al. Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir. Virology 511, 175\u2013183 (2017). https:\/\/doi.org\/10.1016\/j.virol.2017.08.004 57 Hickerson, B. T. et al. Pathogenesis of Rift Valley Fever Virus Aerosol Infection in STAT2 Knockout Hamsters. Viruses 10 (2018). https:\/\/doi.org\/10.3390\/v10110651 58 Atkins, C. et al. Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters. J Infect Dis 218, S438\u2013S447 (2018). https:\/\/doi.org\/10.1093\/infdis\/jiy457 59 Ranadheera, C. et al. Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis. Sci Rep 10, 12378 (2020). https:\/\/doi.org\/10.1038\/s41598-020-69054-3 60 Emonet, S. F. et al. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease. J Virol 85, 1473\u20131483 (2011). https:\/\/doi.org\/10.1128\/JVI.02102-10 61 Fan, Z. et al. Efficient gene targeting in golden Syrian hamsters by the CRISPR\/Cas9 system. PLoS One 9, e109755 (2014). https:\/\/doi.org\/10.1371\/journal.pone.0109755 62 Li, R. et al. A novel cancer syndrome caused by KCNQ1-deficiency in the golden Syrian hamster. J Carcinog 17, 6 (2018). https:\/\/doi.org\/10.4103\/jcar.JCar_5_18 63 McKiernan, S. H. & Bavister, B. D. Culture of one-cell hamster embryos with water soluble vitamins: pantothenate stimulates blastocyst production. Hum Reprod 15, 157\u2013164 (2000). https:\/\/doi.org\/10.1093\/humrep\/15.1.157 64 Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45 (2001). https:\/\/doi.org\/10.1093\/nar\/29.9.e45 65 Daniels-Wells, T. R. et al. An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication. J Immunother 43, 48\u201352 (2020). https:\/\/doi.org\/10.1097\/CJI.0000000000000304 66 Gowen, B. B. et al. In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections. Antimicrob Agents Chemother 51, 3168\u20133176 (2007). https:\/\/doi.org\/10.1128\/AAC.00356-07 67 Sidwell, R. W., Huffman, J. H., Barnett, B. B. & Pifat, D. Y. In vitro and in vivo Phlebovirus inhibition by ribavirin. Antimicrob Agents Chemother 32, 331\u2013336 (1988). https:\/\/doi.org\/10.1128\/AAC.32.3.331 68 LJ Reed, H. M. A simple method of estimating fifty per cent endpoints. Am J Hyg 27, 493\u2013495 (1938)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9172948\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9172948\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:57:09Z","timestamp":1774940229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9172948\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":44,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9172948\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,3,31]]},"subtype":"preprint"}}